Neogen Stock Surges Following Strong First-Quarter Performance and Lifted Outlook
Neogen reported first-quarter revenue of $222.8 million, exceeding analyst expectations by roughly 5%, while adjusted earnings per share swung to a profit of $0.08 against consensus forecasts for a loss. The company raised its fiscal 2027 guidance and demonstrated significant margin expansion, with adjusted EBITDA margin improving 170 basis points driven by operating leverage and lower integration costs.
Neogen's performance reflected strength across both operating divisions. The Food Safety segment, representing roughly 73% of quarterly revenue, achieved 7.4% year-over-year growth with particular momentum in testing products and sanitation services. Animal Safety grew more modestly at 4.2%, though underlying demand accelerated when adjusted for timing effects. Geographic expansion proved broad-based, with international markets generating slightly more revenue than domestic operations and Asia Pacific posting double-digit gains.
The company's margin improvement stemmed from operational efficiencies rather than pricing power. Fixed costs were absorbed across a larger revenue base while integration expenses from the acquired 3M Food Safety business declined. Management attributed the turnaround to reduced restructuring costs and volume leverage, positioning the business for improved profitability as integration matures and scale increases.
Neogen's results may signal improving efficiency in food safety and animal health sectors, potentially benefiting businesses reliant on testing, compliance, and pathogen detection services. Customers in food production and veterinary care could experience better product availability and service as the company stabilizes operations. However, investors should note that reported growth partially reflects distributor inventory adjustments and order timing rather than underlying demand shifts, suggesting actual market momentum may be more measured than headline figures indicate.